236
Participants
Start Date
January 24, 2025
Primary Completion Date
September 19, 2025
Study Completion Date
December 12, 2025
RGT001-075
RGT001-075 is a small molecule GLP-1 agonist
Placebo Comparator
Placebo comparator
Velocity Clinical Research, Vestal
Velocity Clinical Research, Rockville
Velocity Clinical Research, Durham
Javara-Tryon Medical Partners, PLLC, Charlotte
Javara-Privia Medical Group, Georgia LLC, Savannah
Javara-Privia Medical Group, Georgia, LLC, Thomasville
Synexus Clinical Research, The Villages
Optimal Research, Melbourne
Palm Springs Community Health Center, Miami Lakes
Angels Clinical Research, Doral
Angels Clinical Research, Miami
Alliance for Multispecialty Research, LLC, Mobile
Alliance for Multispecialty Research, LLC, Lexington
Velocity Clinical Research, Cleveland
Velocity Clinical Research, Cincinnati
Velocity Clinical Research, Valparaiso
Synexus Clinical Research, Evansville
Synexus Clinical Research, Richfield
Mankato Clinic-East Main Street-Javara, Mankato
Synexus Clinical Research, Creve Coeur
Velocity Clinical Research, Omaha
Velocity Clinical Research, Baton Rouge
Alliance for Multispecialty Research, LLC, Norman
Velocity Clinical Research, Dallas
Synexus Clinical Research, Dallas
Velocity Clinical Research, Waco
Javara-Privia Medical Group Gulf Coast PLLC, The Woodlands
Synexus Clinical Research, San Antonio
Velocity Clinical Research, West Jordan
Synexus Clinical Research, Salt Lake City
Synexus Clinical Research, Phoenix
Velocity Clinical Research, Huntington Park
Velocity Clinical Research, Seattle
Premier Health Research-Sparta-Objective Health, Sparta
Velocity Clinical Research, East Greenwich
Regor Pharmaceuticals Inc.
INDUSTRY